secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALX ONCOLOGY HOLDINGS INC (ALXO)
CIK:        0001810182
Form:       8-K
Filed at:   2024-10-04T23:59:59+00:00
Accession:  0000950170-24-112734
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ALX Oncology CMO Sophia Randolph resigns; separation includes $503,880 and accelerated vesting
--------------------------------------------------------------------------------

- CMO Sophia Randolph resigns effective Oct 11, 2024; she leaves to pursue other professional opportunities.
- Separation agreement includes $503,880 lump sum payment plus COBRA coverage for up to 18 months.
- Outstanding stock options and RSUs that would vest in 12 months post-separation will fully vest; options exercisable until July 11, 2026.
- Company will commence a search for a new Chief Medical Officer.
- She will provide transition consulting services via a consulting agreement for up to 18 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810182/000095017024112734/0000950170-24-112734-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810182/000095017024112734/alxo-20240930.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-112734

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer